Michael Perry
Director at Arrowhead Pharmaceuticals; Director at AVITA Medical. Based in Pasadena, California.
- Rank
- 9891st of 14,644
- Companies held
- 2
- Largest holding
- ARWR, 57.0% of total
- Latest SEC filing
- Aug 18, 2026
What the $8.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals ARWR Common Stock | Directly | 111,459 | $43.65 | $4.9M | 57.0% | Form 4, Aug 18, 2026 |
| AVITA Medical RCEL Common Stock | Directly | 229,543 | $15.98 | $3.7M | 43.0% | Form 4, Nov 21, 2022 |
Share counts are the amounts Michael Perry reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 9888 | Narasimha Kini Executive Vice President, ExlService Holdings. New York, NY | $8.5M |
| 9889 | Jeffrey Klingler Chief Operating Officer, Worthington Steel. Columbus, OH | $8.5M |
| 9890 | Kathleen R McClure Chief Financial Officer, Accenture. Santa Clara, CA | $8.5M |
| 9891 | Michael Perry Director, Arrowhead Pharmaceuticals. Pasadena, CA | $8.5M |
| 9892 | Gary M. Owens President and CEO, Mesa Laboratories. Lakewood, CO | $8.5M |
| 9893 | Robert F. Barton Executive Vice President & CFO, American Assets Trust. San Diego, CA | $8.5M |
| 9894 | Todd S. Nelson President and CEO, Perdoceo Education. Schaumburg, IL | $8.5M |
Other Arrowhead Pharmaceuticals insiders
All ARWR insiders- Christopher Anzalone$166MChief Executive Officer. #1024 overall
- Patrick O'Brien$23.9MCOO. #4536 overall
- Kenneth Myszkowski$19.9MChief Financial Officer. #5220 overall
- James Hamilton$9.9MChief Medical Officer. #8852 overall
- Javier San Martin$8.7MChief Medical Officer. #9742 overall
- Daniel Joseph Apel$7.1MChief Financial Officer. #11273 overall
Questions
How much stock does Michael Perry own?
Michael Perry holds $8,533,282 in listed stock based on SEC filings and current prices, mostly Arrowhead Pharmaceuticals (ARWR). That ranks 9891st on the Stock Rich List.
Is this Michael Perry's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Michael Perry last buy or sell stock?
The most recent open-market trade on file is a sale of 11,600 ARWR shares on Aug 18, 2026 at $87.30.